- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04481425
Evaluation of the Efficacy of Non-drug Therapy (SMS Intervention) for Adolescents With NSSI
November 17, 2022 updated by: Jian-Jun Ou, Central South University
In this proposed study, Text messages are used to intervene in the NSSI behavior of adolescents, and the efficacy of this intervention method is evaluated, as well as the internal mechanism of adolescents' NSSI behavior is discussed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this proposed study, the investigators will evaluate the effect of text message intervention on Nonsuicidal self-injury behavior in adolescents.
The study will recruit 110 adolescents with Nonsuicidal self-injury behavior in outpatient and ward, then all the participants will be randomized to the intervention group (55 cases) or the control group 55 cases) for an 8-week clinic trial.
Clinical efficacy and safety assessment will be done at baseline, the fourth week, and the eighth week.
The specific aims are to evaluate the effect of text message intervention on NSSI in adolescents are on 1) Tendency and frequency of Nonsuicidal self-injury behavior; 2) Level of negative emotion such as depression, anxiety, and hopelessness 3) The use of emotion regulation strategies and coping styles.
A semi-structured quantitative interview will be conducted among adolescents from the SMS group to get the attitude and experiences feedback about the text message.
Study Type
Interventional
Enrollment (Actual)
86
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410000
- Department of Psychiatry, Xiangya Second Hospital, Central South University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 19 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adolescents aged 10-19 years old.
- Meet the diagnostic criteria of NSSI behavior recommended by DSM-5.
- The adolescents who have mobile phone, and have the ability to send or receive text messages.
- Adolescents and guardians agreed to participate and signed the informed consent form
Exclusion Criteria:
- Adolescents with severe somatic diseases who cannot complete the study.
- Adolescents with cognitive impairment, neurodevelopmental disorder, mental retardation, visual impairment who cannot complete the study.
- The adolescents who do not have a mobile phone.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: intervention group
Text messages will be sent to the subjects through the investigator, including giving popularization of psychiatric knowledge, coping skills, emotional regulation strategies, and brief care.
Two or three times a week for two months.
|
SMS intervention
|
|
NO_INTERVENTION: control group
Subjects both collected in the outpatient department and the ward were randomly divided into the control group and regularly followed up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of NSSI behavior of the participants.
Time Frame: At baseline, the fourth week, the eighth week
|
NSSI behavior will be measured by Nonsuicidal self-injury Questionnaire which contains several items designed by investigators.
The questionnaire is mainly used to measure the frequency of NSSI among adolescents.
|
At baseline, the fourth week, the eighth week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of anxiety level.
Time Frame: At baseline, the fourth week, the eighth week
|
The Generalized Anxiety Disorder 7-item Scale will be used to measure the change of anxiety.
GAD-7 scale consists of 7 items.
Each item ranging from 0 to 3, and the total score ranging from 0 to 21.
The higher score indicates severe anxiety symptoms.
|
At baseline, the fourth week, the eighth week
|
|
The change of depression level.
Time Frame: At baseline, the fourth week, the eighth week
|
The Patient Health Questionnaire 9-item will be used to measure the change of depression.
PHQ-9 scale consists of 9 items.
Each item raging from 0 to 3, and the total score ranging from 0 to 27.
The higher score indicates severe depression symptoms.
|
At baseline, the fourth week, the eighth week
|
|
The change of hopelessness.
Time Frame: At baseline, the fourth week, the eighth week
|
The Beck Hopelessness Scale will be used to measure the change of hopelessness.
BHS scale consists of 20 items.
Each item can be answered "yes" or "no" for 1 or 0 points respectively.
The total score ranging from 0 to 20.
A higher total score indicates a higher degree of hopelessness.
|
At baseline, the fourth week, the eighth week
|
|
The change of emotion regulation strategies.
Time Frame: At baseline, the fourth week, the eighth week
|
The Emotion Regulation Questionnaire will be used to measure the change of emotion regulation styles.
ERQ scale consists of 10 items which can be divided into cognitive reappraisal and expression suppression two emotion-regulating strategy subscales.
Each item ranging from 1 to 7 points.
The higher the score, the more often the respondent used this emotion-regulating strategy.
|
At baseline, the fourth week, the eighth week
|
|
The change of coping styles.
Time Frame: At baseline, the fourth week, the eighth week
|
The Simplified Coping Style Questionnaire will be used to measure the change of coping styles.
SCSQ scale consists of 20 items which can be divide into positive coping styles and negative coping styles in two dimensions.
Each item raging from 0 to 3, and the total score ranging from 0 to 60.
The higher the score, the more likely the respondents are to use this coping style.
|
At baseline, the fourth week, the eighth week
|
|
The change of life events stress.
Time Frame: At baseline, the fourth week, the eighth week
|
The Adolescent Self-Rating Life Events Check-list will be used to measure the frequency and intensity of life events that may trigger a stressful psychological response in adolescents.
There are 27 items in the scale, which can be divided into 6 dimensions.
The scale scores ranged from 27 to 135.
The higher the score means the higher the degree of negative life event stress.
The scale is widely used in China and has good reliability and validity.
|
At baseline, the fourth week, the eighth week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 23, 2020
Primary Completion (ACTUAL)
January 30, 2022
Study Completion (ACTUAL)
January 30, 2022
Study Registration Dates
First Submitted
July 13, 2020
First Submitted That Met QC Criteria
July 17, 2020
First Posted (ACTUAL)
July 22, 2020
Study Record Updates
Last Update Posted (ACTUAL)
November 18, 2022
Last Update Submitted That Met QC Criteria
November 17, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MD20200309
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-suicidal Self-injury
-
University of ManchesterCompletedNon-Suicidal Self InjuryUnited Kingdom
-
Central South UniversityRecruitingSuicidal Ideation | Suicide and Self-harm | Non Suicidal Self InjuryChina
-
Tel-Aviv Sourasky Medical CenterRecruiting
-
Shantou University Medical CollegeCompletedNon Suicidal Self InjuryChina
-
Fatima Jinnah Women UniversityCompletedSuicidal Ideation | Psychological Distress | Non-Suicidal Self InjuryPakistan
-
Jian-Jun OuNot yet recruitingNon-suicidal Self-injury (NSSI)China
-
Jian-Jun OuRecruitingNon-suicidal Self-injury (NSSI)China
-
Xijing HospitalEnrolling by invitationAdolescent | Depression | Non-suicidal Self-injury (NSSI)China
-
Anhui Medical UniversityRecruitingTranscranial Direct Current Stimulation | Non Suicidal Self InjuryChina
-
Anhui Medical UniversityRecruitingNon-suicidal Self-injuryChina
Clinical Trials on SMS intervention
-
Fundación Cardiovascular de ColombiaLondon School of Hygiene and Tropical Medicine; University College, London; Universidad...Completed
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR); Institute for Clinical Evaluative...CompletedSchizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Bipolar Disorder | Psychosis | Schizophreniform Disorders | Substance Induced Psychoses | Psychotic Episode | First Episode Psychosis | Psychoses, Affective | Depressive PsychosisCanada
-
University of RochesterNational Cancer Institute (NCI)CompletedCervical CancerUnited States
-
Harvard Medical School (HMS and HSDM)Partners in HealthActive, not recruitingCOVID-19 | Mental Health | MisinformationHaiti, Malawi, Rwanda
-
University of Missouri, St. LouisRecruiting
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)CompletedType2 DiabetesUnited States
-
Mayo ClinicCompletedTobacco Smoking | Tobacco Use Cessation | Perioperative/Postoperative ComplicationsUnited States
-
Washington University School of MedicineThe Foundation for Barnes-Jewish HospitalCompletedStroke | Multiple Sclerosis | Spinal Cord InjuriesUnited States
-
Addis Ababa UniversityFogarty International Center of the National Institute of HealthUnknownTuberculosis | UndernutritionEthiopia
-
The University of Hong KongCompletedComparative Effectiveness Research | Community-Based Participatory ResearchChina